EGFR and cancer: We next wanted to test the non-additive effect of the PA + NRs combination in EGFR expression in the cancer cell line MDA-MB-231 (which is more aggressive than the MCF-7 cancer cell line tested in Fig. 2), where both PLD2 and EGFR are abundantly expressed.